AIDS News and Research

RSS

AIDS activists to protest BMS' Reyataz pricing, policies at Goldman Sachs Global Healthcare Conference

“All of AHF's efforts, including this protest, are designed to let people know that BMS is causing great harm to people with HIV/AIDS with its unwarranted pricing of Reyataz”

15 Jun 2010

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

15 Jun 2010

NBC's TODAY Show to focus on PF in an interview with a patient from California

The Coalition for Pulmonary Fibrosis announced today one of the first major national media coverage opportunities for the CPF and Pulmonary Fibrosis. NBC's TODAY Show will focus on the disease in an interview with California patient Bob O'Rourke, who suffers from the disease and will die from it unless he receives a lung transplant in time.

15 Jun 2010

Canada invites Africa, Caribbean, South American leaders to meeting during upcoming G8 summit

Canadian Prime Minister Stephen Harper on Sunday invited several leaders from Africa, the Caribbean and South America "to a meeting on development and security issues, to be held on the sidelines of the G8 summit later this month," Agence France-Presse reports.

15 Jun 2010

Media examine Women Deliver conference

As the conference closed, Women Deliver President Jill Sheffield said advocates would address the economic dimensions of maternal mortality, the BBC reports. "Finance ministers are on our list - and they're not going to stay safe," she said. "They don't always see this as a critical issue. Our economic arguments for investing in women's health are pretty dramatic."

15 Jun 2010

New form of artificial human skin

Australian researchers are on the road to the discovery of a new form of artificial human skin that could be a boon to burn victims and other patients needing skin grafts. At present the available skin grafts are only 1 millimeter thick and serve only to replace the top epidermis layer.

14 Jun 2010

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

Researchers have shown that a cheap and easy to use drug that stops bleeding may save up to 100,000 lives each year from injuries associated with road accidents and violence. The study was published this Tuesday in the acclaimed international journal The Lancet and was conducted by doctors at the London School of Hygiene and Tropical Medicine.

14 Jun 2010

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.

14 Jun 2010

State round-up: Tenn. lawmakers fail to pass bill to opt out of health care law; Mass. officials continue to study hospital sale

Tennessee lawmakers adjourned the 106th General Assembly early Thursday after failing to pass a bill to opt out of the new federal health care law. ... Both chambers passed the budget -- the only piece of legislation they are constitutionally required to adopt -- last week, but spent the last few days wrangling over issues like the federal health care overhaul.

14 Jun 2010

TIME series examines global health

As part of a special package about global health, TIME magazine visits what is known as "the most malarial town on earth" - Apac, Uganda - and examines global malaria control and efforts to eradicate the disease.

14 Jun 2010

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

More than 2,400 participants in AIDS/LifeCycle arrived at the Veterans Center in Los Angeles today after traveling 545 miles from San Francisco over the past seven days in the world's largest annual HIV/AIDS fundraising event. In its ninth year, the event raised $10 million to support the services of San Francisco AIDS Foundation and the L.A. Gay & Lesbian Center that prevent new HIV infections and care for those living with HIV/AIDS.

14 Jun 2010

BIOTECanada congratulates CPHA on 100 years of leadership in public health

As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.

11 Jun 2010

Community-based model of DOT improves HIV patient survival: Researchers

When applied to HIV care, the community-based model of directly observed therapy has no effect on virologic outcomes, but significantly improves patient survival. This is according to researchers at the Johns Hopkins Bloomberg School of Public Health, in collaboration with colleagues at University of Cape Town, South Africa, who conducted the first randomized controlled trial of patient-nominated treatment-supporters providing partial DOT in resource-limited settings.

11 Jun 2010

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

At a meeting which ended last night, the Executive Board of UNITAID approved a plan to step up efforts to enlist more countries to apply a solidarity levy on air tickets to provide additional funding for the health Millennium Development Goals. The Board approved a number of resolutions, among them the final phase of the establishment of a medicines patent pool, but a situation of depleting funds raises concerns for the many patients currently being treated by UNITAID.

11 Jun 2010

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

ViroStatics, srl, an Italian-US biopharmaceutical company today announced the formation of a strategic partnership with Vichem Chemie of Budapest, Hungary to identify, synthesize, screen, and develop the next generation of AntiViral-HyperActivation Limiting Therapeutics (AV-HALTs) for the treatment of HIV/AIDS and other chronic diseases.

11 Jun 2010

New methodology may help control influenza

Scientists have uncovered the flu's secret formula for effectively evolving within and between host species: balance. The key lies with the flu's unique replication process, which has evolved to produce enough mutations for the virus to spread and adapt to its host environment, but not so many that unwanted genomic mutations lead to the flu's demise (catastrophic mutagenesis).

11 Jun 2010

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

11 Jun 2010

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

The draft conclusions for the U.N.'s Millennium Development Goals (MDGs) summit in September, which were distributed to governments last week, call on world leaders to follow through on promises of aid money to help countries reach the benchmarks established in 2000, Reuters reports.

11 Jun 2010

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

The coalition Make Poverty History released a report on Wednesday, which praises Canada's spending on food aid and programs aimed at fighting diseases such as HIV/AIDS, tuberculosis and malaria, but it also says Canada should spend more on its maternal and child health G8 initiative, the Canadian Press/CTV News reports.

11 Jun 2010

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Most of the time, the body's blood-forming (hematopoietic) stem cells remain dormant, with just a few producing blood cells and maintaining a balance among the different types.

10 Jun 2010

AIDS News and Research

AIDS activists to protest BMS' Reyataz pricing, policies at Goldman Sachs Global Healthcare Conference

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

NBC's TODAY Show to focus on PF in an interview with a patient from California

Canada invites Africa, Caribbean, South American leaders to meeting during upcoming G8 summit

Media examine Women Deliver conference

New form of artificial human skin

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

State round-up: Tenn. lawmakers fail to pass bill to opt out of health care law; Mass. officials continue to study hospital sale

TIME series examines global health

AIDS/LifeCycle event raises $10M to support HIV/AIDS services

BIOTECanada congratulates CPHA on 100 years of leadership in public health

Community-based model of DOT improves HIV patient survival: Researchers

UNITAID approves plan: Solidarity levy to provide funding for health Millennium Development Goals

ViroStatics, Vichem Chemie partner to discover new AV-HALT drugs

New methodology may help control influenza

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

U.N. MDG summit draft conclusions call for aid promise follow through, highlight progress and challenges

Report urges Canada to increase foreign aid spending for G8 maternal, child health initiative

Gamma interferon wakes-up sleeping stem cells to produce immune system cells to fight invading bacteria

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News